Close Menu
Home » Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds

Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds

May 17, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Beam Therapeutics announced today that it has launched with $87 million in Series A funding to develop precision genetic medicines that make edits to individual base pairs in the genome.

The funding round was led by F-Prime Capital Partners and ARCH Venture Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

PLOS Papers Look at Gut Mycobacterium Abscessus, Preterm Birth Transcriptomics, More

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

All That Plastic in the Lab

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

Now Here

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.

Garlic Helps, Too

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

What's Popular?

In Business News

  1. Invitae to Acquire Genetic Counseling Chatbot Developer for $50M

  2. Illumina Unveils Liquid Biopsy Version of TSO 500 Panel, Highlights Early User Validations

    Premium

  3. Expedeon to Sell Proteomics, Immunology Businesses to Abcam for $130M

  4. Guardant Health Q3 Revenues Spike 181 Percent

  5. MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.